# Effect of Zydena (Udenafil) on Cerebral Blood Flow and Peripheral Blood Viscosity

> **NCT01466543** · PHASE2 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Vascular Dementia
- Subcortical Vascular Dementia

## Interventions

- **DRUG:** Zydena (Udenafil)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01466543
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-11
- **Primary completion:** 2012-03
- **Final completion:** 2012-11
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2011-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01466543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01466543, "Effect of Zydena (Udenafil) on Cerebral Blood Flow and Peripheral Blood Viscosity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01466543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*